Filing Details
- Accession Number:
- 0001293301-12-000050
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-07 15:55:04
- Reporting Period:
- 2012-08-03
- Filing Date:
- 2012-12-07
- Accepted Time:
- 2012-12-07 15:55:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
38074 | Forest Laboratories Inc | FRX | Pharmaceutical Preparations (2834) | 111798614 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1509230 | Jerome Lynch | C/O Forest Laboratories, Inc. 909 Third Avenue New York NY 10022 | Svp-Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-08-03 | 646 | $32.77 | 70,154 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-08-03 | 854 | $32.76 | 69,300 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-12-05 | 1,988 | $35.87 | 67,312 | No | 4 | F | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | F | Direct |
Footnotes
- This amount includes shares of common stock which are subject to a risk of forfeiture.